Lazard Asset Management LLC Emergent Bio Solutions Inc. Transaction History

Lazard Asset Management LLC

$61.8 Billion
Q4 2024

A detailed history of Lazard Asset Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 55,303 shares of EBS stock, worth $426,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,303

Previous 8,627 541.05%

Holding current value

$426,386

Previous $72,000 633.33%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.72 - $11.97 $360,338 - $558,711	46,676 Added 541.05%	55,303 $528,000
Q3 2024 Nov 14, 2024	SELL	$5.72 - $14.77 $530,993 - $1.37 Million	-92,831 Reduced 91.5%	8,627 $72,000
Q2 2024 Aug 14, 2024	BUY	$1.86 - $6.98 $188,711 - $708,176	101,458 New	101,458 $691,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $84,898 - $211,845	26,782 New	26,782 $91,000
Q4 2022 Feb 14, 2023	BUY	$11.0 - $21.45 $52,613 - $102,595	4,783 New	4,783 $56,000
Q1 2022 May 13, 2022	BUY	$36.48 - $52.22 $65,007 - $93,056	1,782 New	1,782 $73,000
Q4 2021 Feb 09, 2022	SELL	$33.11 - $55.01 $41,751 - $69,367	-1,261 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$50.07 - $66.05 $11,566 - $15,257	-231 Reduced 15.48%	1,261 $63,000
Q2 2021 Aug 12, 2021	SELL	$56.61 - $80.46 $20.9 Million - $29.7 Million	-369,646 Reduced 99.6%	1,492 $93,000
Q1 2021 May 14, 2021	BUY	$86.23 - $125.19 $1.88 Million - $2.73 Million	21,814 Added 6.24%	371,138 $34.5 Million
Q4 2020 Feb 11, 2021	BUY	$79.17 - $111.47 $1.2 Million - $1.7 Million	15,206 Added 4.55%	349,324 $31.3 Million
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $432,730 - $712,888	5,283 Added 1.61%	334,118 $34.5 Million
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $2.5 Million - $4.11 Million	-45,935 Reduced 12.26%	328,835 $26 Million
Q1 2020 May 14, 2020	SELL	$49.34 - $68.76 $8.11 Million - $11.3 Million	-164,285 Reduced 30.48%	374,770 $21.7 Million
Q4 2019 Feb 13, 2020	SELL	$51.21 - $59.06 $2.93 Million - $3.37 Million	-57,140 Reduced 9.58%	539,055 $29.1 Million
Q3 2019 Nov 14, 2019	SELL	$40.6 - $57.2 $5.01 Million - $7.06 Million	-123,435 Reduced 17.15%	596,195 $31.2 Million
Q2 2019 Aug 14, 2019	BUY	$39.92 - $53.86 $28.7 Million - $38.8 Million	719,630 New	719,630 $34.8 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Account

Lazard Asset Management LLC Emergent Bio Solutions Inc. Transaction History